JAMP-Pregabalin pain pills recalled over overdose risk

JAMP Pharma Corp. has issued a recall for one lot of JAMP-Pregabalin pain medication due to a labeling error that could potentially lead to serious health risks. The affected bottles, which are supposed to contain 50-milligram capsules, may actually contain 150-milligram capsules instead. This discrepancy in dosage could result in patients receiving a much higher dose than prescribed, potentially leading to an overdose.

Health Canada has warned that the mislabelled product poses significant health risks, including the possibility of fatal consequences. JAMP-Pregabalin is a prescription drug commonly used in adults to manage pain caused by nerve damage from conditions such as diabetes, shingles, spinal cord injury, and fibromyalgia.

Symptoms of a pregabalin overdose may include sudden mood changes, sleepiness, confusion, depression, agitation, restlessness, and seizures. It is particularly dangerous to take excessive amounts of pregabalin while also using other central nervous system-acting drugs, such as opioids, as this combination has been linked to heart electrical issues, seizures, and even death.

If you suspect that you may have taken an overdose of pregabalin, it is crucial to seek immediate medical attention. Additionally, patients should not abruptly discontinue their pregabalin treatment, as this could lead to withdrawal symptoms like insomnia, nausea, headache, anxiety, excessive sweating, diarrhea, and convulsions.

If you have been prescribed 50-milligram capsules of JAMP-Pregabalin and believe that you may have received the higher dosage in error, or if you are unsure about the contents of your medication bottle, Health Canada advises returning it to your pharmacy. If returning the product is not immediately feasible, it is recommended to consult with your pharmacist or healthcare provider for further guidance.

The affected product was distributed nationwide, so patients across the country should take caution and follow the recall instructions provided by Health Canada. It is essential to prioritize patient safety and ensure that medication is accurately labeled and dispensed to prevent any potential harm.